Oak Thistle LLC Makes New $3.30 Million Investment in The Clorox Company (NYSE:CLX)

Oak Thistle LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 22,375 shares of the company's stock, valued at approximately $3,295,000. Clorox comprises about 0.7% of Oak Thistle LLC's investment portfolio, making the stock its 24th largest holding.

Other hedge funds also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC purchased a new stake in Clorox in the 4th quarter valued at about $26,000. Millstone Evans Group LLC purchased a new stake in Clorox in the 4th quarter valued at about $31,000. Wood Tarver Financial Group LLC purchased a new stake in Clorox in the 4th quarter valued at about $31,000. GKV Capital Management Co. Inc. purchased a new stake in Clorox in the 4th quarter valued at about $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in Clorox in the 4th quarter valued at about $33,000. 78.53% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Citigroup restated a "neutral" rating and set a $135.00 price target (down previously from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. JPMorgan Chase & Co. cut their price target on Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a research note on Friday. Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Jefferies Financial Group lowered their price target on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Finally, Morgan Stanley lowered their price target on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Clorox has an average rating of "Hold" and an average target price of $144.83.

Insider Buying and Selling

In other news, Director Pierre R. Breber bought 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was bought at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the transaction, the director directly owned 4,000 shares of the company's stock, valued at approximately $546,280. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is owned by insiders.

Clorox Stock Down 0.5%

NYSE:CLX traded down $0.62 during midday trading on Friday, reaching $130.80. 1,287,038 shares of the stock traded hands, compared to its average volume of 1,776,629. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37. The business has a 50-day moving average of $126.77 and a two-hundred day moving average of $140.29. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The stock has a market capitalization of $16.12 billion, a PE ratio of 23.48, a price-to-earnings-growth ratio of 3.46 and a beta of 0.51.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The firm had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.74 billion. During the same period in the previous year, the company earned $1.71 EPS. The company's revenue was down 8.0% on a year-over-year basis. On average, equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.